Results 51 to 60 of about 2,289,660 (191)

Imaging Needs in Novel Transcatheter Tricuspid Valve Interventions

JACC: Cardiovascular Imaging, 2018
The advent of novel transcatheter therapies for severe tricuspid regurgitation (TR) has attracted much attention. Novel 3-dimensional imaging techniques have permitted analysis of the tricuspid valve (TV) anatomy from unparalleled views and better understanding of the underlying pathophysiology of TR.
Prihadi, E.A., Delgado, V., Hahn, R.T., Leipsic, J., Min, J.K., Bax, J.J.   +5 more
openaire   +3 more sources

Transcatheter Tricuspid Valve Intervention in Patients With Previous Left Valve Surgery

Canadian Journal of Cardiology, 2021
BACKGROUND Scarce data exist on patients with previous left valve surgery (PLVS) undergoing transcatheter tricuspid valve intervention (TTVI). This study sought to investigate the procedural and early outcomes in patients with PLVS undergoing TTVI. METHODS This was a subanalysis of the multicenter TriValve registry including 462 patients, 82 (18%) with
Guillem, Muntané-Carol, Maurizio, Taramasso, Mizuki, Miura, Mara, Gavazzoni, Alberto, Pozzoli, Hannes, Alessandrini, Azeem, Latib, Adrian, Attinger-Toller, Luigi, Biasco, Daniel, Braun, Eric, Brochet, Kim A, Connelly, Horst, Sievert, Paolo, Denti, Edith, Lubos, Sebastian, Ludwig, Daniel, Kalbacher, Rodrigo, Estevez-Loureiro, Neil, Fam, Christian, Frerker, Edwin, Ho, Jean-Michel, Juliard, Ryan, Kaple, Susheel, Kodali, Felix, Kreidel, Claudia, Harr, Alexander, Lauten, Julia, Lurz, Karl-Patrik, Kresoja, Vanessa, Monivas, Michael, Mehr, Tamim, Nazif, Georg, Nickening, Giovanni, Pedrazzini, François, Philippon, Fabien, Praz, Rishi, Puri, Ulrich, Schäfer, Joachim, Schofer, Gilbert H L, Tang, Ahmed A, Khattab, Martin, Andreas, Marco, Russo, Holger, Thiele, Matthias, Unterhuber, Dominique, Himbert, Marina, Urena, Ralph Stephan, von Bardeleben, John G, Webb, Marcel, Weber, Mirjam, Winkel, Michel, Zuber, Jörg, Hausleiter, Philipp, Lurz, Francesco, Maisano, Martin B, Leon, Rebecca T, Hahn, Josep, Rodés-Cabau   +57 more
openaire   +2 more sources

Transcatheter Tricuspid Valve Clinical Trials: Incomplete Data and FDA-Approved Devices

Structural Heart
Each reviewed trial of transcatheter tricuspid valve intervention demonstrated clinically meaningful improvement in Kansas City Cardiomyopathy Questionnaire (KCCQ)-defined quality of life and favorable right ventricular remodeling.
Deborah Furman, MD, Brian Whisenant, MD
doaj   +1 more source

State-of-the-Art Review: Anatomical and Imaging Considerations During Transcatheter Tricuspid Valve Repair Using an Annuloplasty Approach

Frontiers in Cardiovascular Medicine, 2021
Transcatheter techniques for the treatment of tricuspid regurgitation (TR) are being more frequently used and several new devices are in development.
Nina C. Wunderlich, Melanie Landendinger, Martin Arnold, Stephan Achenbach, Martin J. Swaans, Robert J. Siegel, Siew Yen Ho   +6 more
doaj   +1 more source

Implantable Systems for Cardiovascular Treatment and Monitoring: Comparative Insights From Intracardiovascular and Extracardiovascular Technologies

Advanced Intelligent Systems, EarlyView.
A unifying device–cardiovascular interface framework is presented to classify implantable cardiovascular technologies as intracardiovascular blood‐contacting systems or extracardiovascular tissue‐only and blood‐handling architectures. Cross‐class comparison across shared semiquantitative criteria, including blood‐contact burden, biomimicry ...
Bergo Nicolò, Semproni Federica, Maselli Martina, Colli Andrea, Cianchetti Matteo, Ciuti Gastone, Stefanini Cesare, Menciassi Arianna   +7 more
wiley   +1 more source

Early Experience With Evoque Transcatheter Tricuspid Valve Replacement in Carcinoid Heart Disease

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Tricuspid regurgitation (TR) is nearly universal in carcinoid heart disease (CHD), but surgical replacement carries significant risk, and CHD was excluded from the landmark TRISCEND II trial. We present seven patients with CHD undergoing Evoque transcatheter tricuspid valve replacement (TTVR) at two tertiary centers.
Jackson S. Burton, Ben Peterson, Brian Whisenant, Anwar Tandar   +3 more
wiley   +1 more source

Case report of a transcatheter tricuspid valve-in-valve replacement [PDF]

Transcatheter valve implantations in the tricuspid position are infrequent. We report a case of an Edwards SAPIEN 3 (S3) implantation in the tricuspid position as a transcatheter valve-in-valve procedure in a 12-year-old patient deemed at high risk for ...
Pillay, DN, Brown, SC, Buys, DG
core   +1 more source

Outcomes of Transcatheter Tricuspid Valve-in-Valve Implantation in Patients With Ebstein Anomaly. [PDF]

, 2018
We sought to describe the acute results and short- to medium-term durability of transcatheter tricuspid valve-in-valve (TVIV) implantation within surgical bioprostheses among patients with Ebstein anomaly (EA).
Taggart, Nathaniel W, Thomas K. Jones, Boudjemline, Younes, Fagan, Thomas E, Brian Whisenant, Jeffery Meadows, Mary H. Martin, Delaney, Jeffrey W, Turner, Daniel R, John D.R. Thomson, Mark Hoyer, Eicken, Andreas, Younes Boudjemline, Schubert, Stephan, Jeremy D. Asnes, Frank F. Ing, Thomson, John D R, Foerster, Susan, McElhinney, Doff B, Stephan Windecker, Allison K. Cabalka, Shahanavaz, Shabana, James A. Kuo, Doff B. McElhinney, Matthew Gillespie, Aboulhosn, Jamil A, Jeffrey W. Delaney, Daniel R. Turner, Stephan Schubert, Whisenant, Brian, Daniel Dvir, Asnes, Jeremy D, Gillespie, Matthew, Ing, Frank F, Dvir, Daniel, Thomas E. Fagan, Eric Horlick, Gianfranco Butera, Martin L. Bocks, Bryan H. Goldstein, Kuo, James A, Aphrodite Tzifa, Hoyer, Mark, Bocks, Martin L, Shabana Shahanavaz, Tzifa, Aphrodite, Cabalka, Allison K, Windecker, Stephan, Latib, Azeem, Horlick, Eric, Azeem Latib, Susan Foerster, Goldstein, Bryan H, Meadows, Jeffery, Martin, Mary H, Butera, Gianfranco, Jones, Thomas K, Nathaniel W. Taggart, Andreas Eicken, Jamil A. Aboulhosn   +59 more
core   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source